SCHEMBL18196121

SCHEMBL18196121

CC[C@@H]1CC[C@H](NC(=O)c2ccccc2)C(=O)O1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
DDB1 Q16531 1/20 0.46
CRBN Q96SW2 1/20 0.46
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.41
HPGD P15428 2/20 0.41
CARM1 Q86X55 1/20 0.40
PRMT6 Q96LA8 1/20 0.40
PKM P14618 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
LMNA P02545 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5275706 0.77 ALDH1A1 (0.46) ALDH1A1DDB1CRBNHTTHPGD
SCHEMBL16579918 0.74 ALDH1A1 (0.55) ALDH1A1DDB1CRBNMEN1KMT2A
SCHEMBL10454044 0.74 ALDH1A1 (0.55) ALDH1A1DDB1CRBNMEN1KMT2A
SCHEMBL7039408 0.70 DDB1 (0.52) ALDH1A1DDB1CRBNHTTPKM
SCHEMBL11903535 0.68 DDB1 (0.65) ALDH1A1DDB1CRBNHTTPKM
SCHEMBL15014140 0.68 MEN1 (0.61) NPSR1HPGDCARM1PRMT6NPC1
SCHEMBL20740124 0.68 ALDH1A1 (0.51) ALDH1A1DDB1CRBNHTTPKM
SCHEMBL18387872 0.68 MEN1 (0.61) NPSR1HPGDCARM1PRMT6NPC1
SCHEMBL15014137 0.68 MEN1 (0.61) NPSR1HPGDCARM1PRMT6NPC1
SCHEMBL10562127 0.68 ALDH1A1 (0.48) ALDH1A1DDB1CRBNHTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790181-B2 Method for producing 5-hydroxypiperidine-2-carboxylic acid API CORPORATION (JP) 2017-10-17 US disclosed
EP-3091002-A1 METHOD FOR PRODUCING 5-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID API Corporation (JP) 2016-11-09 EP disclosed
US-20160318867-A1 METHOD FOR PRODUCING 5-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID API CORPORATION (JP) 2016-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318867-A1 METHOD FOR PRODUCING 5-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID HPD, ADCY5, CYP2A7 ALDH1A1 132/4885DDB1 4766/4885CRBN 4571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.